11th Feb 2026 10:36
(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Wednesday.
----------
SMALL-CAP - WINNERS
----------
PZ Cussons PLC, up 8.1% at 86.76 pence, 12-month range 65.09p-91.70p. The personal healthcare products and consumer goods firm reports revenue for the six months ended November 29 of GBP269.3 million, up 8.0% from GBP249.3 million a year earlier, while pretax profit multiplies to GBP34.3 million from GBP6.4 million. PZ Cussons keeps its interim dividend flat at 1.50p per share and says trading to the end of January is in line with expectations. The company lifts financial 2026 adjusted operating profit guidance to between GBP53 million and GBP57 million from GBP50 million to GBP55 million earlier. This would be flat with GBP54.9 million in financial 2025. PZ Cussons also unveils a renewed strategy following the conclusion of its December strategic review, targeting mid-single-digit percentage like-for-like revenue growth and high-single-digit operating profit and earnings per share growth.
----------
Picton Property Income Ltd, up 5.2% at 87.38 pence, 12-month range 62.50p-90.00p. The real estate investment trust confirms it has received interest from FTSE 100-listed LondonMetric Property PLC regarding its formal sales process. Picton says LondonMetric has been granted a dispensation from the Takeover Code requirements and is not subject to the usual 28-day deadline to announce a firm intention to make an offer.
----------
SMALL-CAP - LOSERS
----------
Genflow Biosciences PLC, down 27% at 1.53p, 12-month range 0.55p-2.70p. The London-based biotechnology firm calls a general meeting on March 2 to seek shareholder approval to issue up to 188.9 million new shares, representing around 38% of its existing issued share capital, as part of a potential equity raise. Genflow says there is no certainty the fundraise will proceed, adding that no agreements have yet been entered into to subscribe for new shares.
----------
MJ Gleeson PLC, down 11% at 350.10p, 12-month range 320.00p-538.00p. The housebuilder reports revenue for the half year that ended December 31 of GBP173.1 million, up from GBP157.9 million a year prior, but it says pretax profit falls to GBP1.7 million from GBP3.6 million as margins come under pressure, with net selling price increases outpaced by build-cost inflation. MJ Gleeson keeps its interim dividend flat at 4.0p per share and says full-year 2026 market expectations are "achievable", although this depends on a strong Spring selling season. The company says it is "cautiously encouraged" by early signs of recovery in open market demand. CEO Graham Prothero says: "For the full year, whilst current market expectations remain achievable, a strong Spring selling season remains fundamental to our assumptions in delivering on those expectations and we need to see the recovery gain further momentum. The bulk market has softened further, as investors remain cautious and focused on pricing. Margins continue to be pressured as net selling price increases are outpaced by build costs, and we experience increasing regulatory and tax headwinds. We will update our guidance in April 2026 with the benefit of greater trading visibility through to the year end."
----------
By Eva Castanedo, Alliance News reporter
Comments and questions to [email protected]
Copyright 2026 Alliance News Ltd. All Rights Reserved.
Related Shares:
Genflow BiosciMJGleesonPz CussonsPicton PropLondonMetric